# Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps

> **NCT03102190** · PHASE1 · TERMINATED · sponsor: **Benjamin Bleier** · enrollment: 6 (actual)

## Conditions studied

- Sinusitis
- Nasal Polyps

## Interventions

- **DRUG:** Verapamil Hydrochloride Intranasal

## Key facts

- **NCT ID:** NCT03102190
- **Lead sponsor:** Benjamin Bleier
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-05
- **Primary completion:** 2018-03-26
- **Final completion:** 2018-03-26
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Phase II funding not available
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03102190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03102190, "Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03102190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*